The American Journal of Medicine
Volume 118, Issue 9 , Pages 1004-1009, September 2005

White blood cell count and the incidence of ischemic stroke in coronary heart disease patients

  • Nira Koren-Morag, PhD

      Affiliations

    • Division of Epidemiology, Sackler Medical faculty, Tel Aviv University, Israel.
    • Stroke Unit, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.
  • ,
  • David Tanne, MD

      Affiliations

    • Division of Epidemiology, Sackler Medical faculty, Tel Aviv University, Israel.
    • Stroke Unit, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.
  • ,
  • Uri Goldbourt, PhD

      Affiliations

    • Division of Epidemiology, Sackler Medical faculty, Tel Aviv University, Israel.
    • Stroke Unit, Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel.
    • Corresponding Author InformationRequests for reprints should be addressed to Uri Goldbourt, PhD, Professor of Epidemiology, Sackler Medical Faculty, Tel Aviv University, Tel Aviv 69978, Israel.

Abstract 

Purpose

White blood cell (WBC) count is a marker of inflammation and has been associated with the development of cardiovascular disease. We investigated the relationship between WBC counts and the incidence of ischemic cerebrovascular disease in a large cohort of patients with pre-existing atherothrombotic disease and defined blood lipid boundaries.

Subjects and methods

We followed up patients with documented coronary heart disease for 4.8 to 8.1 years. An extensive medical evaluation, conducted at baseline, included assessment of vascular risk factors and measures of blood lipids. Among 5435 patients with WBC counts, free of stroke, 295 developed an ischemic cerebrovascular disease (fatal and nonfatal). After review of available medical records, 186 of these cases had ischemic stroke or TIA.

Results

Higher WBC counts were associated with increased risk for ischemic cerebrovascular disease. Age-adjusted hazard ratio (HR) was 1.55 with 95% confidence interval (CI) 1.16-2.07, upper WBC tertile compared with the lowest. Adjusting for clinical covariates, WBC count remained an independent predictor for ischemic cerebrovascular disease (HR = 1.39; 95% CI 1.03-1.87, upper WBC tertile compared with the lowest). A similar trend appeared for the endpoint of ischemic stroke/transient ischemic attack (TIA). Further adjustment for plasma fibrinogen did not change the association materially (HR = 1.32; 95% CI 1.01-1.80; upper tertile of WBC compared with lowest).

Conclusions

These findings support the role of WBC count as a simple inexpensive and readily available marker for risk stratification of ischemic cerebrovascular disease among patients with pre-existing atherothrombotic disease and defined blood lipid boundaries.

Keywords:  White blood cell , Ischemic cerebrovascular disease , Coronary disease

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0002-9343(05)00205-6

doi:10.1016/j.amjmed.2005.03.010

The American Journal of Medicine
Volume 118, Issue 9 , Pages 1004-1009, September 2005